View Clinical Trial (Medical Research Study)
Short Course Glucocorticoid Treatment for PTSD - NCT00204737-53711(Clinical Trial 130181)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Madison |
|
State:
|
|
WI |
| Zip Code: |
|
53711 |
| Conditions: |
|
Post-Traumatic Stress Disorder |
| Purpose: |
|
The purpose of this study is to investigate if a 2-wk course of 20mg/day of oral prednisone
in addition to standard care will result in reduced PTSD symptoms or symptom severity
compared to placebo
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Must meet DSM-IV criteria for PTSD w/ symptom exacerbation (CAPS score ≥ 50)
- Stable on other psychotropic meds x1 month
Exclusion Criteria:
- Current or past history of bipolar, schizophrenic, or other psychotic disorder
- Organic mental disorder
- Alcohol or substance abuse in last 3 months
- Clinically significant hepatic or renal disease or other acute or unstable medical
condition
- COPD, asthma, uncontrolled diabetes, rheumatologic diseases |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
July 12, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|